← Back to Clinical Trials
Recruiting NCT04242069

NCT04242069 Healthy for my Baby- RCT of a Lifestyle Intervention for Overweight Women in Preconception

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04242069
Status Recruiting
Phase
Sponsor Université de Sherbrooke
Condition Overweight and Obesity
Study Type INTERVENTIONAL
Enrollment 68 participants
Start Date 2021-06-18
Primary Completion 2025-12-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 40 Years
Study Type INTERVENTIONAL
Interventions
Healthy for my BabyUsual Care

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 68 participants in total. It began in 2021-06-18 with a primary completion date of 2025-12-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to determine whether an intervention combining motivational interviewing and follow-up with a mobile phone application will help overweight women and their partners adopt healthy lifestyle habits in the preconception period. This study will also evaluate the impact of the intervention on the weight, waist circumference, and body fat of women and their partners. Women and their partners will be followed through pregnancy to explore the effects of the intervention on the adequacy of gestational weight gain, rates of pregnancy complications, delivery mode, and infant birth weight.

Eligibility Criteria

Inclusion Criteria: * Women and their partner who wish to conceive within 12 months of trial inclusion * Woman's body mass index ≥ 25 kg/m2 * Access to a smart phone Exclusion Criteria: * Insufficient knowledge of French or English * Anticipated move to another region * Personal history of infertility * Type 1 or 2 diabetes mellitus * Prior bariatric surgery * Active eating disorder established by clinical diagnosis * Medical contraindication to pregnancy * Medical contraindication to physical activity * Participation in another intensive lifestyle intervention * Known or anticipated disease or surgery likely to cause an important weight loss * Multiple pregnancies will be excluded from the pregnancy follow-up to limit aberrant data

Contact & Investigator

Central Contact

Ana C Colmenares, MD

✉ ensantepourbebe@usherbrooke.ca

📞 1-819-674-3780

Principal Investigator

William D Fraser, MD,MSc

PRINCIPAL INVESTIGATOR

Researcher, Centre de recherche du CHUS

Frequently Asked Questions

Who can join the NCT04242069 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Overweight and Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04242069 currently recruiting?

Yes, NCT04242069 is actively recruiting participants. Contact the research team at ensantepourbebe@usherbrooke.ca for enrollment information.

Where is the NCT04242069 trial being conducted?

This trial is being conducted at Québec, Canada, Sherbrooke, Canada.

Who is sponsoring the NCT04242069 clinical trial?

NCT04242069 is sponsored by Université de Sherbrooke. The principal investigator is William D Fraser, MD,MSc at Researcher, Centre de recherche du CHUS. The trial plans to enroll 68 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology